No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

27 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

NCT00116844Phase 4Completed73 enrolled

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00126997Phase 4Completed1439 enrolled

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

NCT00161434Phase 4Completed60 enrolled

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

NCT00326183Phase 4Completed1800 enrolled

A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand

NCT00362596Phase 4Completed67 enrolled

View all 27 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.

Miwa Naoko, Kurosaki Kunikazu, Yoshida Yoshihiro et al. · Antiviral Res · 2005

PMID: 15652971Observational

Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine.

Oh K W, Lee C K, Kim Y S et al. · J Ethnopharmacol · 2000

PMID: 10967475Observational

Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation.

Vianelli N, Renga M, Azzi A et al. · Bone Marrow Transplant · 2000

PMID: 10673705Case Report

Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation.

Seabra C, Pérez-Simón J A, Sierra M et al. · Bone Marrow Transplant · 2000

PMID: 11149737Case Report

Vidarabine as a novel antifungal agent against Candida albicans: insights on mechanism of action.

Gavandi Tanjila C, Basrani Sargun T, Chougule Sayali A et al. · Int Microbiol · 2025

PMID: 39126447Other

Exploring the anticancer activities of Sulfur and magnesium oxide through integration of deep learning and fuzzy rough set analyses based on the features of Vidarabine alkaloid.

Askr Heba, Fayed Marwa A A, Farghaly Heba Mamdouh et al. · Sci Rep · 2025

PMID: 39824867OtherFull text (PMC)

SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of vidarabine against rotenone-induced neural cell injury.

Li Lanxin, Zhang Yang, Chen Zhengqian et al. · Heliyon · 2023

PMID: 38027872OtherFull text (PMC)

Inosine, AMP, and Vidarabine: Network Pharmacology and LC-MS Reveal Key Bioactive Compounds infor Ulcerative Colitis Management.

Li Yue, Shi Zheng-Mei, He Yong et al. · Int J Mol Sci · 2025

PMID: 40564909PreclinicalFull text (PMC)

Water-soluble vidarabine derivatives alleviate catecholamine-induced heart failure and arrhythmia without impairing cardiac function in mice.

Suita Kenji, Hayakawa Yoshio, Hoshino Yujiro et al. · PLoS One · 2025

PMID: 40833980PreclinicalFull text (PMC)

A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota.

Gao Xiaoyu, Guo Kaifeng, Liu Shuangfeng et al. · Int J Mol Sci · 2024

PMID: 39684522PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Vidarabine (substance)
SNOMED CT: 373759007
UMLS CUI: C0042646
RxNorm CUI: 11194

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.